Luis De Taboada

Mr. Luis De Taboada

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2010 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
JHJavad T. Hashmi
Javad T. Hashmi
YHYing‐Ying Huang
Ying‐Ying Huang
SSSulbha K. Sharma
Sulbha K. Sharma
DKDivya Balachandran Kurup
Divya Balachandran Kurup
LTLuis De Taboada
Luis De Taboada
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

1 October 2006 in Stroke
Verified
Journal Article
Open access
PDF file
AOAmir Oron
Amir Oron
UOUri Oron
Uri Oron
JCJieli Chen
Jieli Chen
AEAnda Eilam
Anda Eilam
CZChunling Zhang
Chunling Zhang
MCMichael Chopp
Michael Chopp
Background and Purpose— Low-level laser therapy (LLLT) modulates various biological processes. In the present study, we assessed the hypothesis that LLLT after induction of stroke may have a beneficial effect on ischemic brain tissue. Methods— Two sets of experiments were performed. Stroke was induced in rats by (1) permanent occlusion of the middle cerebral artery through a craniotomy or (2) insertion of a filament. After induction of stroke, a battery of neurological and functional tests (neurological score, adhesive removal) was performed. Four and 24 hours poststroke, a Ga-As diode laser was used transcranially to illuminate the hemisphere contralateral to the stroke at a power density of 7.5 mW/cm 2 . Results— In both models of stroke, LLLT significantly reduced neurological deficits when applied 24 hours poststroke. Application of the laser at 4 hours poststroke did not affect the neurological outcome of the stroke-induced rats as compared with controls. There was no statistically significant difference in the stroke lesion area between control and laser-irradiated rats. The number of newly formed neuronal cells, assessed by double immunoreactivity to bromodeoxyuridine and tubulin isotype III as well as migrating cells (doublecortin immunoactivity), was significantly elevated in the subventricular zone of the hemisphere ipsilateral to the induction of stroke when treated by LLLT. Conclusions— Our data suggest that a noninvasive intervention of LLLT issued 24 hours after acute stroke may provide a significant functional benefit with an underlying mechanism possibly being induction of neurogenesis.

14 February 2011 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
LTLuis De Taboada
Luis De Taboada
JYJin Yu
Jin Yu
SESalim El-Amouri
Salim El-Amouri
SGSebastiano Gattoni-Celli
Sebastiano Gattoni-Celli
SRSteve Richieri
Steve Richieri
MKMark S. Kindy
Mark S. Kindy
Transcranial laser therapy (TLT) was tested for efficacy in a mouse model of Alzheimer's disease (AD) using a near-infrared energy laser system. TLT is thought to stimulate ATP production, increase mitochondrial activity, and help maintain neuronal f

1 April 2007 in Journal of Neurotrauma
Verified
Journal Article
Closed access
AOAmir Oron
Amir Oron
UOUri Oron
Uri Oron
JSJackson Streeter
Jackson Streeter
LTLuis De Taboada
Luis De Taboada
AAAlexander Alexandrovich
Alexander Alexandrovich
ESEsther Shohami
Esther Shohami
Low-level laser therapy (LLLT) has been evaluated in this study as a potential therapy for traumatic brain injury (TBI). LLLT has been found to modulate various biological processes. Following TBI in mice, we assessed the hypothesis that LLLT might have a beneficial effect on their neurobehavioral and histological outcome. TBI was induced by a weight-drop device, and motor function was assessed 1 h post-trauma using a neurological severity score (NSS). Mice were then divided into three groups of eight mice each: one control group that received a sham LLLT procedure and was not irradiated; and two groups that received LLLT at two different doses (10 and 20 mW/cm2 ) transcranially. An 808-nm Ga-As diode laser was employed transcranially 4 h post-trauma to illuminate the entire cortex of the brain. Motor function was assessed up to 4 weeks, and lesion volume was measured. There were no significant changes in NSS at 24 and 48 h between the laser-treated and non-treated mice. Yet, from 5 days and up to 28 days, the NSS of the laser-treated mice were significantly lower (p < 0.05) than the traumatized control mice that were not treated with the laser. The lesion volume of the laser treated mice was significantly lower (1.4%) than the non-treated group (12.1%). Our data suggest that a non-invasive transcranial application of LLLT given 4 h following TBI provides a significant long-term functional neurological benefit. Further confirmatory trials are warranted.

26 September 2011 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
SSSulbha K. Sharma
Sulbha K. Sharma
GKGitika B. Kharkwal
Gitika B. Kharkwal
MSMari Sajo
Mari Sajo
YHYing‐Ying Huang
Ying‐Ying Huang
LTLuis De Taboada
Luis De Taboada
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin

1 June 2007 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
UOUri Oron
Uri Oron
SIS. Ilic
S. Ilic
LTLuis De Taboada
Luis De Taboada
JSJ. Streeter
J. Streeter
Objective: The aim of the present study was to investigate whether Ga-As laser irradiation can enhance adenosine triphosphate (ATP) production in normal human neural progenitor (NHNP) cells in culture. Methods: NHNP were grown in tissue culture and were treated by Ga-As laser (808 nm, 50 mW/cm 2 , 0.05 J/cm 2 ), and ATP was determined at 10 min after laser application. Results: The quantity of ATP in laser-treated cells was 7513 ± 970 units, which was significantly higher ( p < 0.05) than the non-treated cells, which comprised 3808 ± 539 ATP units. Conclusion: Laser application to NHNP cells significantly increases ATP production in these cells. These findings may explain the beneficial effects of low-level laser therapy (LLLT) in stroked rats. Tissue culture of NHNP cells might offer a good model to study the mechanisms associated with promotion of ATP production in the nervous system by LLLT.